117 related articles for article (PubMed ID: 21145258)
1. Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters.
Greig D; Alcaino H; Castro PF; Garcia L; Verdejo HE; Navarro M; López R; Mellado R; Tapia F; Gabrielli LA; Nogerol C; Chiong M; Godoy I; Lavandero S
J Heart Lung Transplant; 2011 Apr; 30(4):408-13. PubMed ID: 21145258
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
[TBL] [Abstract][Full Text] [Related]
3. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure.
Tousoulis D; Antoniades C; Vassiliadou C; Toutouza M; Pitsavos C; Tentolouris C; Trikas A; Stefanadis C
Eur J Heart Fail; 2005 Dec; 7(7):1126-32. PubMed ID: 16051518
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans.
Liuni A; Luca MC; Di Stolfo G; Uxa A; Mariani JA; Gori T; Parker JD
J Am Coll Cardiol; 2011 Jan; 57(1):93-8. PubMed ID: 21185507
[TBL] [Abstract][Full Text] [Related]
6. Allopurinol improves endothelial dysfunction in chronic heart failure.
Farquharson CA; Butler R; Hill A; Belch JJ; Struthers AD
Circulation; 2002 Jul; 106(2):221-6. PubMed ID: 12105162
[TBL] [Abstract][Full Text] [Related]
7. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
George J; Carr E; Davies J; Belch JJ; Struthers A
Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
[TBL] [Abstract][Full Text] [Related]
8. Statins: a treatment option for chronic heart failure?
von Haehling S; Okonko DO; Anker SD
Heart Fail Monit; 2004; 4(3):90-7. PubMed ID: 15772704
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure.
Amado LC; Saliaris AP; Raju SV; Lehrke S; St John M; Xie J; Stewart G; Fitton T; Minhas KM; Brawn J; Hare JM
J Mol Cell Cardiol; 2005 Sep; 39(3):531-6. PubMed ID: 15963530
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.
Strey CH; Young JM; Molyneux SL; George PM; Florkowski CM; Scott RS; Frampton CM
Atherosclerosis; 2005 Mar; 179(1):201-6. PubMed ID: 15721028
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
Tousoulis D; Andreou I; Tentolouris C; Antoniades C; Papageorgiou N; Gounari P; Kotrogiannis I; Miliou A; Charakida M; Trikas A; Stefanadis C
Int J Cardiol; 2010 Dec; 145(3):438-43. PubMed ID: 19539384
[TBL] [Abstract][Full Text] [Related]
12. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
[TBL] [Abstract][Full Text] [Related]
13. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure.
Mozaffarian D; Minami E; Letterer RA; Lawler RL; McDonald GB; Levy WC
Am J Cardiol; 2005 Dec; 96(12):1699-704. PubMed ID: 16360360
[TBL] [Abstract][Full Text] [Related]
14. Allopurinol and endothelial function in heart failure: future or fantasy?
Landmesser U; Drexler H
Circulation; 2002 Jul; 106(2):173-5. PubMed ID: 12105153
[No Abstract] [Full Text] [Related]
15. Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study.
Tousoulis D; Koniari K; Antoniades C; Miliou A; Noutsou M; Nikolopoulou A; Papageorgiou N; Marinou K; Stefanadi E; Stefanadis C
Clin Ther; 2010 Sep; 32(10):1720-8. PubMed ID: 21194594
[TBL] [Abstract][Full Text] [Related]
16. HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study.
Mackie FE; Rosenberg AR; Harmer JA; Kainer G; Celermajer DS
Acta Paediatr; 2010 Mar; 99(3):457-9. PubMed ID: 20050832
[No Abstract] [Full Text] [Related]
17. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris.
Rajendra NS; Ireland S; George J; Belch JJ; Lang CC; Struthers AD
J Am Coll Cardiol; 2011 Aug; 58(8):820-8. PubMed ID: 21835317
[TBL] [Abstract][Full Text] [Related]
18. Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome.
Chyrchel M; Dudek D; Rzeszutko L; Dziewierz A; Chyrchel B; Rakowski T; Dubiel JS
Cardiovasc Revasc Med; 2011; 12(1):2-9. PubMed ID: 21241965
[TBL] [Abstract][Full Text] [Related]
19. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
van der Harst P; Wagenaar LJ; Buikema H; Voors AA; Plokker HW; Morshuis WJ; Six AJ; Boonstra PW; Nickenig G; Wassmann S; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2005 Nov; 96(10):1361-4. PubMed ID: 16275178
[TBL] [Abstract][Full Text] [Related]
20. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
Antoniades C; Bakogiannis C; Tousoulis D; Reilly S; Zhang MH; Paschalis A; Antonopoulos AS; Demosthenous M; Miliou A; Psarros C; Marinou K; Sfyras N; Economopoulos G; Casadei B; Channon KM; Stefanadis C
Circulation; 2010 Sep; 122(11 Suppl):S66-73. PubMed ID: 20837928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
